Molecular analysis of cell-free circulating DNA for the diagnosis of somatic mutations associated with resistance to tyrosine kinase inhibitors in non-small-cell lung cancer.
about
Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancerDynamic monitoring of EGFR mutations in circulating cell-free DNA for EGFR-mutant metastatic patients with lung cancer: Early detection of drug resistance and prognostic significanceAZD9291 in EGFR-mutant advanced non-small-cell lung cancer patients.Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine?Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA.Evidence-based best practices for EGFR T790M testing in lung cancer in Canada.
P2860
Molecular analysis of cell-free circulating DNA for the diagnosis of somatic mutations associated with resistance to tyrosine kinase inhibitors in non-small-cell lung cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Molecular analysis of cell-fre ...... in non-small-cell lung cancer.
@en
type
label
Molecular analysis of cell-fre ...... in non-small-cell lung cancer.
@en
prefLabel
Molecular analysis of cell-fre ...... in non-small-cell lung cancer.
@en
P2860
P50
P1476
Molecular analysis of cell-fre ...... in non-small-cell lung cancer.
@en
P2093
Enrico Vasile
P2860
P304
P356
10.1586/14737159.2014.908120
P577
2014-04-11T00:00:00Z